These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 30316729)
21. Distinct progression pattern of susceptibility MRI in the substantia nigra of Parkinson's patients. Du G; Lewis MM; Sica C; He L; Connor JR; Kong L; Mailman RB; Huang X Mov Disord; 2018 Sep; 33(9):1423-1431. PubMed ID: 29756399 [TBL] [Abstract][Full Text] [Related]
22. Substantia nigra echogenicity correlated with clinical features of Parkinson's disease. Zhou HY; Sun Q; Tan YY; Hu YY; Zhan WW; Li DH; Wang Y; Xiao Q; Liu J; Chen SD Parkinsonism Relat Disord; 2016 Mar; 24():28-33. PubMed ID: 26842545 [TBL] [Abstract][Full Text] [Related]
23. Diffusion Kurtosis Imaging for Detection of Early Brain Changes in Parkinson's Disease. Guan J; Ma X; Geng Y; Qi D; Shen Y; Shen Z; Chen Y; Wu E; Wu R Front Neurol; 2019; 10():1285. PubMed ID: 31920913 [TBL] [Abstract][Full Text] [Related]
24. Does normal substantia nigra echogenicity make a difference in Parkinson's disease diagnosis? A real clinical practice follow-up study. Alonso-Canovas A; Lopez-Sendon Moreno JL; Buisan J; Sainz de la Maza S; Costa-Frossard L; Garcia-Ribas G; de Felipe-Mimbrera A; Matute-Lozano MC; Zarza Sanz B; Toledano Delgado R; Corral I; Masjuan J; Martinez-Castrillo JC J Neurol; 2018 Oct; 265(10):2363-2369. PubMed ID: 30116942 [TBL] [Abstract][Full Text] [Related]
25. Diffusion tensor imaging of the substantia nigra in Parkinson's disease revisited. Langley J; Huddleston DE; Merritt M; Chen X; McMurray R; Silver M; Factor SA; Hu X Hum Brain Mapp; 2016 Jul; 37(7):2547-56. PubMed ID: 27029026 [TBL] [Abstract][Full Text] [Related]
26. Microstructural changes in the substantia nigra of asymptomatic agricultural workers. Du G; Lewis MM; Sterling NW; Kong L; Chen H; Mailman RB; Huang X Neurotoxicol Teratol; 2014; 41():60-4. PubMed ID: 24334261 [TBL] [Abstract][Full Text] [Related]
27. Combination of Quantitative Susceptibility Mapping and Diffusion Kurtosis Imaging Provides Potential Biomarkers for Early-Stage Parkinson's Disease. Rong Y; Xu Z; Zhu Y; Zhang X; Lai L; Sun S; Gao M; Guo P; Zhang G; Geng Y; Ma X; Wu S; Yang L; Shen Z; Guan J ACS Chem Neurosci; 2022 Sep; 13(18):2699-2708. PubMed ID: 36047877 [No Abstract] [Full Text] [Related]
28. Free water and iron content in the substantia nigra at different stages of Parkinson's disease. Chen M; Wang Y; Zhang C; Li J; Li Z; Guan X; Bao J; Zhang Y; Cheng J; Wei H Eur J Radiol; 2023 Oct; 167():111030. PubMed ID: 37579561 [TBL] [Abstract][Full Text] [Related]
29. Utility of quantitative susceptibility mapping and diffusion kurtosis imaging in the diagnosis of early Parkinson's disease. Tan S; Hartono S; Welton T; Ann CN; Lim SL; Koh TS; Li H; Setiawan F; Ng S; Chia N; Liu S; Mark Haacke E; King Tan E; Chew Seng Tan L; Ling Chan L Neuroimage Clin; 2021; 32():102831. PubMed ID: 34619654 [TBL] [Abstract][Full Text] [Related]
30. High-Spatial-Resolution Diffusion MRI in Parkinson Disease: Lateral Asymmetry of the Substantia Nigra. Zhong Z; Merkitch D; Karaman MM; Zhang J; Sui Y; Goldman JG; Zhou XJ Radiology; 2019 Apr; 291(1):149-157. PubMed ID: 30777809 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of Substantia Nigra morphology in Parkinson's Disease. Durmaz Çelik N; Yaman Kula A; Toprak U; Saylısoy S; Topal A; Özkan S Medicine (Baltimore); 2024 Mar; 103(12):e37538. PubMed ID: 38518035 [TBL] [Abstract][Full Text] [Related]
32. Quantitative assessment of iron deposition in the midbrain using 3D-enhanced T2 star weighted angiography (ESWAN): a preliminary cross-sectional study of 20 Parkinson's disease patients. Wang C; Fan G; Xu K; Wang S Magn Reson Imaging; 2013 Sep; 31(7):1068-73. PubMed ID: 23746648 [TBL] [Abstract][Full Text] [Related]
33. Lateralized microstructural changes in early-stage Parkinson's disease in anterior olfactory structures, but not in substantia nigra. Joshi N; Rolheiser TM; Fisk JD; McKelvey JR; Schoffer K; Phillips G; Armstrong M; Khan MN; Leslie RA; Rusak B; Robertson HA; Good KP J Neurol; 2017 Jul; 264(7):1497-1505. PubMed ID: 28653210 [TBL] [Abstract][Full Text] [Related]
34. Fractional anisotropy in the substantia nigra in Parkinson's disease: a complex picture. Lenfeldt N; Larsson A; Nyberg L; Birgander R; Forsgren L Eur J Neurol; 2015 Oct; 22(10):1408-14. PubMed ID: 26118635 [TBL] [Abstract][Full Text] [Related]
35. Hyperhomocysteinemia can predict the severity of white matter hyperintensities in elderly lacunar infarction patients. Yu L; Yang L; Li Y; Yang S; Gu H; Hu W; Gao S Int J Neurosci; 2020 Mar; 130(3):231-236. PubMed ID: 31744348 [No Abstract] [Full Text] [Related]
36. Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease. Gorell JM; Ordidge RJ; Brown GG; Deniau JC; Buderer NM; Helpern JA Neurology; 1995 Jun; 45(6):1138-43. PubMed ID: 7783878 [TBL] [Abstract][Full Text] [Related]
37. High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease. Vaillancourt DE; Spraker MB; Prodoehl J; Abraham I; Corcos DM; Zhou XJ; Comella CL; Little DM Neurology; 2009 Apr; 72(16):1378-84. PubMed ID: 19129507 [TBL] [Abstract][Full Text] [Related]
38. Impulsivity Relates to Relative Preservation of Mesolimbic Connectivity in Patients with Parkinson Disease. Sparks H; Riskin-Jones H; Price C; DiCesare J; Bari A; Hashoush N; Pouratian N Neuroimage Clin; 2020; 27():102259. PubMed ID: 32361415 [TBL] [Abstract][Full Text] [Related]
39. Substantia nigra neuromelanin magnetic resonance imaging in de novo Parkinson's disease patients. Reimão S; Pita Lobo P; Neutel D; Correia Guedes L; Coelho M; Rosa MM; Ferreira J; Abreu D; Gonçalves N; Morgado C; Nunes RG; Campos J; Ferreira JJ Eur J Neurol; 2015 Mar; 22(3):540-6. PubMed ID: 25534480 [TBL] [Abstract][Full Text] [Related]
40. Substantia nigra echogenicity: A structural correlate of functional impairment of the dopaminergic striatal projection in Parkinson's disease. Weise D; Lorenz R; Schliesser M; Schirbel A; Reiners K; Classen J Mov Disord; 2009 Aug; 24(11):1669-75. PubMed ID: 19514075 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]